AI assistant
MYRIAD GENETICS INC — Director's Dealing 2019
Sep 26, 2019
32566_dirs_2019-09-26_44e9342d-6016-44f3-8302-00fe716e60ac.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2019-09-25
Reporting Person: King Gary A. (Exec. VP International Ops)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-09-25 | Common Stock | D | 2994 | $29.93 | Disposed | 131877 | Direct |
| 2019-09-25 | Common Stock | D | 3327 | $29.93 | Disposed | 128550 | Direct |
| 2019-09-25 | Common Stock | A | 27000 | $0.0 | Acquired | 155550 | Direct |
Footnotes
F1: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person.
F2: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 26, 2020, 25% on September 26, 2021, 25% on September 26, 2022, and 25% on September 26, 2023.